Press release
Respiratory Syncytial Virus Diagnostic Testing Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2013 - 2019
ResearchMoz added Latest Research Report titled " Respiratory Syncytial Virus Diagnostic Testing Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019 " to it's Large Report database.Respiratory syncytial virus (RSV) causes infection of respiratory system (lungs and breathing passage). It may also affect heart and immune system resulting in more serious illnesses (e.g. tachypnea, cyanosis).Premature infants (30-40 days) and children (less than 2 year of age) are at the highest risk of this infection. According to the U.S. Centre for Disease Control and Prevention (CDC), RSV is the common cause of bronchiolitis or pneumonia in the children under one year of age in the United States. Each year 75,000 to 125,000 children are hospitalized due to RSV infections. This Infection can result from the direct (i.e. kiss, touch or shake hands with infected person) or indirect contact (i.e. contact with sneeze, cough or blows of infected person)with the infected person. Mild headache, runny nose, cough and sore throat are some of the common symptoms of RSV viral infections. Diagnosis of these infections is facilitated by specific tests like polymerase chain reaction assay, molecular probes, chest radiography. Physicians also administer intubation (breathing tube), mechanical ventilation or some antibiotics (like palivizumab) in order to treat the patients with RSV infections.
Request for Sample PDF of Premium Research Report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=195911
Increasing incidences of childhood pneumonia, acts as one of the major factors to drive the growth of RSV diagnostic testing market. According to the data enumerated by World Health Organization (WHO), in 2010, approximately 1.1 million people in the United States were hospitalized with pneumonia and 50,000 people died from this disease. In addition, crowded population and unhygienic environment (dirty premises, unhygienic eating places) may increase the chances of RSV infection thereby resulting in increased need and demand for effective RSV diagnostic tests. However, high number of other pathogens that may cause similar symptoms of respiratory illness and lack of availability of specific treatment options to curb this infection may restrain the growth of this market.
Read All In Vitro Diagnostics Market Research Reports @ http://www.researchmoz.us/in-vitro-diagnostics-market-reports-28.html
The global Respiratory Syncytial Virus Diagnostic Testing Market can be segmented as follows:
By Diagnostic Technology
Molecular Diagnostics
Immunoassays
Monoclonal Antibodies
Flow Cytometry
Diagnostic Imaging
Chromatography
Gel Microdroplets
Others
By End Users
Physician offices or group practices
Hospitals
Commercial Laboratories
Nursing Homes
Geographically, North America and Europe dominate the global RSV diagnostic testing market due to increasing patient population suffering from respiratory syncytial virus. According to the U.S. CDC, approximately 50,000 deaths are noted due to pneumonia in the United States in year of 2012.In addition, Asia-Pacific countries such as India and China, South East Asian countries are the emerging regions for global RSV diagnostic testing market due to high prevalence of these diseases (i.e. pneumonia, bronchitis) in these regions and increasing healthcare awareness.
Some of the key players in this industry are Abbott Laboratories, Beckman Coulter, Ortho-Clinical Diagnostics, bioMerieux, F. Hoffman-La Roche, Ltd., Bio-Rad Laboratories, Inc., DiaSorin S.p.A , Novartis Diagnostics, Becton Dickson company and Thermo Fisher Scientific among others.
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
North America
Asia Pacific
Europe
Rest of the World
About ResearchMoz
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:
Mr. Nachiket Ghumare
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Follow me on Blogger at: http://healthcare-research-report.blogspot.in/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Respiratory Syncytial Virus Diagnostic Testing Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2013 - 2019 here
News-ID: 436217 • Views: …
More Releases for RSV
The Rise In The Prevalence Of RSV Infection : Transformative Forces Shaping the …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Respiratory Syncytial Virus (RSV) Therapeutics Industry Market Size Be by 2025?
The market size for therapeutics treating the respiratory syncytial virus (RSV) has seen significant expansion in the past few years. It is expected to surge from $1.6 billion in 2024 to $2 billion in 2025,…
RSV Vaccine Market To Reach 731 million by 2040, Due To Increasing Awareness on …
According to our latest market report "RSV Vaccine Market, Till 2040 by Type of Vaccine, Route of Administration, Target Patient Population, Distribution Channel, Key Geographical Regions and Leading Players", the RSV Vaccine market size is projected to reach USD 731 million by 2040 from USD 1,149 million in current year, during the forecast period.
To request quote of this report, please visit:
https://www.rootsanalysis.com/reports/rsv-vaccine-market/request-quote.html
In the dynamic landscape of preventive therapies for respiratory…
RSV Diagnostics Market to Signify Strong Growth by 2024-2031
The RSV (Respiratory Syncytial Virus) Diagnostics market is experiencing significant growth due to the increasing prevalence of RSV infections, advancements in diagnostic technologies, and the rising demand for accurate and rapid diagnostic solutions. RSV is a common respiratory virus that causes infections in the lungs and respiratory tract, particularly affecting infants, young children, and the elderly.
Market Overview
The global RSV Diagnostics market is projected to witness substantial growth over the coming…
Global RSV Diagnostic Products Market Size & Trends
According to a new market research report published by Global Market Estimates, the global RSV diagnostic products market is expected to grow at a CAGR of 11.4% from 2023 to 2028.
Ongoing advancements in diagnostic technologies, specifically PCR and rapid point-of-care testing, play a crucial role. These advancements offer heightened accuracy, faster results, and increased accessibility, enabling prompt and precise identification of RSV infections.
Browse 147 Market Data Tables and 115 Figures…
Respiratory Syncytial Virus (RSV) Therapeutics Market Size to Reach USD 9080.84 …
Respiratory Syncytial Virus (RSV) Therapeutics Market Scope & Overview
Respiratory Syncytial Virus (RSV) Therapeutics Market size was USD 1040.65 Million in 2022 and is expected to Reach USD 9080.84 Million by 2030 and grow at a CAGR of 31.1% over the forecast period of 2023-2030.
The Respiratory Syncytial Virus (RSV) Therapeutics market is a vibrant, fiercely competitive sector that is essential to digital marketing. The demand for effective has increased as companies…
Respiratory Syncytial Virus (RSV) Therapeutics Market - Conquering RSV: Advancin …
Newark, New Castle, USA: The "Respiratory Syncytial Virus (RSV) Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Respiratory Syncytial Virus (RSV) Therapeutics Market: https://www.growthplusreports.com/report/respiratory-syncytial-virus-rsv-therapeutics-market/8519
This latest report…